Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

School Burnout, Relational, and Organizational Factors.

Parrello S, Ambrosetti A, Iorio I, Castelli L.

Front Psychol. 2019 Aug 2;10:1695. doi: 10.3389/fpsyg.2019.01695. eCollection 2019.

2.

Modulating the cardiotoxic behaviour of immunoglobulin light chain dimers through point mutations.

Maritan M, Ambrosetti A, Oberti L, Barbiroli A, Diomede L, Romeo M, Lavatelli F, Sormanni P, Palladini G, Bolognesi M, Merlini G, Ricagno S.

Amyloid. 2019;26(sup1):105-106. doi: 10.1080/13506129.2019.1583185. No abstract available.

PMID:
31343361
3.

van der Waals interactions in DFT using Wannier functions without empirical parameters.

Silvestrelli PL, Ambrosetti A.

J Chem Phys. 2019 Apr 28;150(16):164109. doi: 10.1063/1.5093125.

PMID:
31042875
4.

Faraday-like Screening by Two-Dimensional Nanomaterials: A Scale-Dependent Tunable Effect.

Ambrosetti A, Silvestrelli PL.

J Phys Chem Lett. 2019 May 2;10(9):2044-2050. doi: 10.1021/acs.jpclett.9b00860. Epub 2019 Apr 12.

PMID:
30964300
5.

Anomalous van der Waals-Casimir interactions on graphene: A concerted effect of temperature, retardation, and non-locality.

Ambrosetti A, Silvestrelli PL.

J Chem Phys. 2018 Apr 7;148(13):134709. doi: 10.1063/1.5023170.

PMID:
29626904
6.

Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.

Tiribelli M, Bonifacio M, Binotto G, Iurlo A, Cibien F, Maino E, Guella A, Festini G, Minotto C, De Biasi E, De Marchi F, Scaffidi L, Frison L, Bucelli C, Medeot M, Calistri E, Sancetta R, Stulle M, Orofino N, Krampera M, Gherlinzoni F, Semenzato G, Pizzolo G, Ambrosetti A, Fanin R.

Oncotarget. 2018 Feb 12;9(18):14219-14227. doi: 10.18632/oncotarget.24478. eCollection 2018 Mar 6.

7.

Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience.

Andreini A, Zampieri N, Costantini C, Malerba G, Bruno C, Salvagno G, Francia G, Gottardi M, Rimondini M, Ferrarini I, Lippi G, Ambrosetti A, Benedetti F, Tecchio C.

Leuk Lymphoma. 2018 Nov;59(11):2719-2722. doi: 10.1080/10428194.2018.1443338. Epub 2018 Mar 21. No abstract available.

PMID:
29561209
8.

Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index.

Nicolini S, Severi S, Ianniello A, Sansovini M, Ambrosetti A, Bongiovanni A, Scarpi E, Di Mauro F, Rossi A, Matteucci F, Paganelli G.

Eur J Nucl Med Mol Imaging. 2018 Jun;45(6):923-930. doi: 10.1007/s00259-017-3925-8. Epub 2018 Feb 1.

PMID:
29387927
9.

CT imaging of primary pancreatic lymphoma: experience from three referral centres for pancreatic diseases.

Boninsegna E, Zamboni GA, Facchinelli D, Triantopoulou C, Gourtsoyianni S, Ambrosetti MC, Veneri D, Ambrosetti A, Pozzi Mucelli R.

Insights Imaging. 2018 Feb;9(1):17-24. doi: 10.1007/s13244-017-0585-y. Epub 2018 Jan 15.

10.

Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis.

Bonifacio M, Zanotti R, Guardalben E, Mimiola E, Scognamiglio F, Perbellini O, De Matteis G, Escribano L, Bonadonna P, Grigolato D, Bissoli S, Parisi A, Zamò A, Ambrosetti A, Rossini M.

Clin Case Rep. 2017 Oct 25;5(12):1988-1991. doi: 10.1002/ccr3.1232. eCollection 2017 Dec.

11.

Two cases of angioimmunoblastic T-cell lymphoma with concomitant positive serology for acute Epstein-Barr virus infection.

Facchinelli D, Polino A, Dima F, Parisi A, Ambrosetti A, Veneri D.

Hematol Rep. 2017 Sep 27;9(3):7088. doi: 10.4081/hr.2017.7088. eCollection 2017 Sep 26. No abstract available.

12.

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.

Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosée P, Binder M, Fabbri A, Torri V, Minacapelli E, Falautano M, Ilariucci F, Ambrosetti A, Roth A, Hemmaway C, Johnson P, Linton KM, Pukrop T, Sønderskov Gørløv J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Levis A, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Pfreundschuh M, Cabras G, Angrilli F, Ponzoni M, Deckert M, Politi LS, Finke J, Reni M, Cavalli F, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).

Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.

PMID:
29054815
13.

Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment-naïve chronic lymphocytic leukemia.

Cavallini C, Visco C, Putta S, Rossi D, Mimiola E, Purvis N, Lovato O, Perbellini O, Falisi E, Facco M, Trentin L, Romanelli MG, Semenzato G, Ambrosetti A, Gaidano G, Pizzolo G, Cesano A, Scupoli MT.

Haematologica. 2017 Apr;102(4):e144-e147. doi: 10.3324/haematol.2016.154450. Epub 2016 Dec 7. No abstract available.

14.

Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed G6PD deficiency.

Veneri D, Facchinelli D, Vianello A, Ambrosetti A, Cantini M, Olivieri O, Dima F, De Franceschi L.

Am J Hematol. 2016 Nov;91(11):1165-1166. doi: 10.1002/ajh.24385. Epub 2016 May 11. No abstract available.

15.

Use of prothrombin complex concentrate for prophylaxis of bleeding in acquired factor X deficiency associated with light-chain amyloidosis.

Veneri D, Giuffrida AC, Bonalumi A, Calabria S, Gandini G, Ambrosetti A, Minuz P.

Blood Transfus. 2016 Nov;14(6):585-586. doi: 10.2450/2016.0335-15. Epub 2016 May 24. No abstract available.

16.

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.

Ferreri AJ, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, Fox CP, Rosée PL, Schorb E, Ambrosetti A, Roth A, Hemmaway C, Ferrari A, Linton KM, Rudà R, Binder M, Pukrop T, Balzarotti M, Fabbri A, Johnson P, Gørløv JS, Hess G, Panse J, Pisani F, Tucci A, Stilgenbauer S, Hertenstein B, Keller U, Krause SW, Levis A, Schmoll HJ, Cavalli F, Finke J, Reni M, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).

Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6.

PMID:
27132696
17.

Communication: Enhanced chemical reactivity of graphene on a Ni(111) substrate.

Ambrosetti A, Silvestrelli PL.

J Chem Phys. 2016 Mar 21;144(11):111101. doi: 10.1063/1.4944090.

PMID:
27004853
18.

Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome.

Carli G, Visco C, Falisi E, Perbellini O, Novella E, Giaretta I, Ferrarini I, Sandini A, Alghisi A, Ambrosetti A, Rodeghiero F.

Ann Hematol. 2016 May;95(6):863-70. doi: 10.1007/s00277-016-2642-x. Epub 2016 Mar 22.

PMID:
27001309
19.

Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia.

Takam Kamga P, Bassi G, Cassaro A, Midolo M, Di Trapani M, Gatti A, Carusone R, Resci F, Perbellini O, Gottardi M, Bonifacio M, Nwabo Kamdje AH, Ambrosetti A, Krampera M.

Oncotarget. 2016 Apr 19;7(16):21713-27. doi: 10.18632/oncotarget.7964.

20.

Wavelike charge density fluctuations and van der Waals interactions at the nanoscale.

Ambrosetti A, Ferri N, DiStasio RA Jr, Tkatchenko A.

Science. 2016 Mar 11;351(6278):1171-6. doi: 10.1126/science.aae0509.

21.

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.

Tiacci E, Park JH, De Carolis L, Chung SS, Broccoli A, Scott S, Zaja F, Devlin S, Pulsoni A, Chung YR, Cimminiello M, Kim E, Rossi D, Stone RM, Motta G, Saven A, Varettoni M, Altman JK, Anastasia A, Grever MR, Ambrosetti A, Rai KR, Fraticelli V, Lacouture ME, Carella AM, Levine RL, Leoni P, Rambaldi A, Falzetti F, Ascani S, Capponi M, Martelli MP, Park CY, Pileri SA, Rosen N, Foà R, Berger MF, Zinzani PL, Abdel-Wahab O, Falini B, Tallman MS.

N Engl J Med. 2015 Oct 29;373(18):1733-47. doi: 10.1056/NEJMoa1506583. Epub 2015 Sep 9.

22.

Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival.

Visco C, Falisi E, Young KH, Pascarella M, Perbellini O, Carli G, Novella E, Rossi D, Giaretta I, Cavallini C, Scupoli MT, De Rossi A, D'Amore ES, Rassu M, Gaidano G, Pizzolo G, Ambrosetti A, Rodeghiero F.

Oncotarget. 2015 Jul 30;6(21):18653-63.

23.

The association of rituximab and a thrombopoietin receptor agonist in high-risk refractory immune thrombocytopenic purpura.

Veneri D, Soligo L, Pizzolo G, Ambrosetti A.

Blood Transfus. 2015 Oct;13(4):694-5. doi: 10.2450/2015.0325-14. Epub 2015 Apr 21. No abstract available.

24.

Electronic properties of molecules and surfaces with a self-consistent interatomic van der Waals density functional.

Ferri N, DiStasio RA Jr, Ambrosetti A, Car R, Tkatchenko A.

Phys Rev Lett. 2015 May 1;114(17):176802. Epub 2015 Apr 27.

PMID:
25978248
25.

Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response.

Bonifacio M, Binotto G, Maino E, Calistri E, Marin L, Scaffidi L, Frison L, De Marchi F, Krampera M, Semenzato G, Fanin R, Ambrosetti A, Tiribelli M; Gruppo Triveneto LMC.

Haematologica. 2015 Aug;100(8):e299-301. doi: 10.3324/haematol.2015.124685. Epub 2015 Mar 27. No abstract available.

26.

Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy.

Tiribelli M, Binotto G, Calistri E, Maino E, Scaffidi L, Medeot M, Nabergoj M, Ambrosetti A, Semenzato G, Fanin R, Bonifacio M; Gruppo Triveneto LMC.

Am J Hematol. 2015 Jul;90(7):E135-7. doi: 10.1002/ajh.24022. Epub 2015 May 28. No abstract available.

27.

Long-range correlation energy calculated from coupled atomic response functions.

Ambrosetti A, Reilly AM, DiStasio RA Jr, Tkatchenko A.

J Chem Phys. 2014 May 14;140(18):18A508. doi: 10.1063/1.4865104.

PMID:
24832316
28.

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.

Arcaini L, Vallisa D, Rattotti S, Ferretti VV, Ferreri AJ, Bernuzzi P, Merli M, Varettoni M, Chiappella A, Ambrosetti A, Tucci A, Rusconi C, Visco C, Spina M, Cabras G, Luminari S, Tucci M, Musto P, Ladetto M, Merli F, Stelitano C, d'Arco A, Rigacci L, Levis A, Rossi D, Spedini P, Mancuso S, Marino D, Bruno R, Baldini L, Pulsoni A.

Ann Oncol. 2014 Jul;25(7):1404-10. doi: 10.1093/annonc/mdu166. Epub 2014 May 5.

PMID:
24799461
29.

Somatic mutations in calreticulin can be found in pedigrees with familial predisposition to myeloproliferative neoplasms.

Lundberg P, Nienhold R, Ambrosetti A, Cervantes F, Pérez-Encinas MM, Skoda RC.

Blood. 2014 Apr 24;123(17):2744-5. doi: 10.1182/blood-2014-01-550863. No abstract available.

PMID:
24764562
30.

Including screening in van der Waals corrected density functional theory calculations: the case of atoms and small molecules physisorbed on graphene.

Silvestrelli PL, Ambrosetti A.

J Chem Phys. 2014 Mar 28;140(12):124107. doi: 10.1063/1.4869330.

PMID:
24697424
31.

177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study.

Paganelli G, Sansovini M, Ambrosetti A, Severi S, Monti M, Scarpi E, Donati C, Ianniello A, Matteucci F, Amadori D.

Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1845-51. doi: 10.1007/s00259-014-2735-5. Epub 2014 Mar 11.

PMID:
24615468
32.

Hard Numbers for Large Molecules: Toward Exact Energetics for Supramolecular Systems.

Ambrosetti A, Alfè D, DiStasio RA Jr, Tkatchenko A.

J Phys Chem Lett. 2014 Mar 6;5(5):849-55. doi: 10.1021/jz402663k. Epub 2014 Feb 17.

PMID:
26274077
33.

Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis.

Magni M, Di Nicola M, Patti C, Scimè R, Mulè A, Rambaldi A, Intermesoli T, Viero P, Tarella C, Gueli A, Bergui L, Trentin L, Barzan A, Benedetti F, Ambrosetti A, Di Raimondo F, Chiarenza A, Parvis G, Billio A, Attolico I, Olivieri A, Montanari M, Carlo-Stella C, Matteucci P, Devizzi L, Guidetti A, Viviani S, Valagussa P, Gianni AM.

Bone Marrow Transplant. 2014 Apr;49(4):485-91. doi: 10.1038/bmt.2013.214. Epub 2014 Jan 20.

PMID:
24442244
34.

Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.

Foà R, Del Giudice I, Cuneo A, Del Poeta G, Ciolli S, Di Raimondo F, Lauria F, Cencini E, Rigolin GM, Cortelezzi A, Nobile F, Callea V, Brugiatelli M, Massaia M, Molica S, Trentin L, Rizzi R, Specchia G, Di Serio F, Orsucci L, Ambrosetti A, Montillo M, Zinzani PL, Ferrara F, Morabito F, Mura MA, Soriani S, Peragine N, Tavolaro S, Bonina S, Marinelli M, De Propris MS, Starza ID, Piciocchi A, Alietti A, Runggaldier EJ, Gamba E, Mauro FR, Chiaretti S, Guarini A.

Am J Hematol. 2014 May;89(5):480-6. doi: 10.1002/ajh.23668. Epub 2014 Feb 18.

35.

Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia.

Perbellini O, Falisi E, Giaretta I, Boscaro E, Novella E, Facco M, Fortuna S, Finotto S, Amati E, Maniscalco F, Montaldi A, Alghisi A, Aprili F, Bonaldi L, Paolini R, Scupoli MT, Trentin L, Ambrosetti A, Semenzato G, Pizzolo G, Rodeghiero F, Visco C.

Haematologica. 2014 May;99(5):881-7. doi: 10.3324/haematol.2013.096362. Epub 2014 Jan 10.

36.

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi.

Merli M, Visco C, Spina M, Luminari S, Ferretti VV, Gotti M, Rattotti S, Fiaccadori V, Rusconi C, Targhetta C, Stelitano C, Levis A, Ambrosetti A, Rossi D, Rigacci L, D'Arco AM, Musto P, Chiappella A, Baldini L, Bonfichi M, Arcaini L.

Haematologica. 2014 Mar;99(3):489-96. doi: 10.3324/haematol.2013.094318. Epub 2013 Nov 22.

37.

Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?

Visco C, Cortelezzi A, Moretta F, Falisi E, Maura F, Finotto S, Barcellini W, Ambrosetti A, Neri A, Ruggeri M, Rodeghiero F.

Leuk Lymphoma. 2014 Jun;55(6):1261-5. doi: 10.3109/10428194.2013.834054. Epub 2013 Sep 23.

PMID:
24047107
38.

Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.

Zaja F, Mian M, Volpetti S, Visco C, Sissa C, Nichele I, Castelli M, Ambrosetti A, Puglisi S, Fanin R, Cortelazzo S, Pizzolo G, Trentin L, Rodeghiero F, Paolini R, Vivaldi P, Sancetta R, Isola M, Semenzato G.

Am J Hematol. 2013 Nov;88(11):955-60. doi: 10.1002/ajh.23546. Epub 2013 Sep 9.

39.

Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia.

Visco C, Moretta F, Falisi E, Facco M, Maura F, Novella E, Nichele I, Finotto S, Giaretta I, Ave E, Perbellini O, Guercini N, Scupoli MT, Trentin L, Trimarco V, Neri A, Semenzato G, Rodeghiero F, Pizzolo G, Ambrosetti A.

Am J Hematol. 2013 Apr;88(4):277-82. doi: 10.1002/ajh.23396. Epub 2013 Feb 28.

40.

Interatomic methods for the dispersion energy derived from the adiabatic connection fluctuation-dissipation theorem.

Tkatchenko A, Ambrosetti A, DiStasio RA Jr.

J Chem Phys. 2013 Feb 21;138(7):074106. doi: 10.1063/1.4789814.

PMID:
23444996
41.

Treatment with the radiolabelled somatostatin analog Lu-DOTATATE for advanced pancreatic neuroendocrine tumors.

Sansovini M, Severi S, Ambrosetti A, Monti M, Nanni O, Sarnelli A, Bodei L, Garaboldi L, Bartolomei M, Paganelli G.

Neuroendocrinology. 2013;97(4):347-54. doi: 10.1159/000348394. Epub 2013 May 22.

PMID:
23392072
42.

Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma.

Munari E, Rinaldi M, Ambrosetti A, Bonifacio M, Bonalumi A, Chilosi M, Zamò A.

Virchows Arch. 2012 Dec;461(6):677-85. doi: 10.1007/s00428-012-1322-z. Epub 2012 Oct 14.

43.

Fertility preservation in cancer patients. Review of the French speaking part of Switzerland and recommendations for different situations.

Wunder D, Perey L; Réseau Romand Cancer et Fertilité, Achtari C, Ambrosetti A, Bellavia M, Delaloye JF, de Ziegler D, Gumy-Pause F, Helg C, Ketterer N, Petignat P, Primi MP, Rosselet-Christ A, Zaman K.

Swiss Med Wkly. 2012 Oct 1;142:w13645. doi: 10.4414/smw.2012.13645. eCollection 2012. Review.

44.

Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL).

Zovato S, Kumanova A, Demattè S, Sansovini M, Bodei L, Di Sarra D, Casagranda E, Severi S, Ambrosetti A, Schiavi F, Opocher G, Paganelli G.

Horm Metab Res. 2012 May;44(5):411-4. doi: 10.1055/s-0032-1311637. Epub 2012 May 7.

PMID:
22566197
45.

Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi.

Merli F, Luminari S, Ilariucci F, Petrini M, Visco C, Ambrosetti A, Stelitano C, Caracciolo F, Di Renzo N, Angrilli F, Carella AM, Capodanno I, Barbolini E, Galimberti S, Federico M.

Br J Haematol. 2012 Feb;156(3):346-53. doi: 10.1111/j.1365-2141.2011.08958.x. Epub 2011 Dec 7.

PMID:
22145911
46.

Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation.

Tiacci E, Schiavoni G, Forconi F, Santi A, Trentin L, Ambrosetti A, Cecchini D, Sozzi E, Francia di Celle P, Di Bello C, Pulsoni A, Foà R, Inghirami G, Falini B.

Blood. 2012 Jan 5;119(1):192-5. doi: 10.1182/blood-2011-08-371179. Epub 2011 Oct 25. Erratum in: Blood. 2013 Aug 29;122(9):1685.

PMID:
22028477
47.

The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience.

Laurenti L, Tarnani M, Nichele I, Ciolli S, Cortelezzi A, Forconi F, Rossi D, Mauro FR, D'Arena G, Del Poeta G, Montanaro M, Morabito F, Musolino C, Callea V, Falchi L, Tedeschi A, Ambrosetti A, Gaidano G, Leone G, Foà R.

Am J Hematol. 2011 Dec;86(12):1007-12. doi: 10.1002/ajh.22171. Epub 2011 Sep 22.

48.

BRAF mutations in hairy-cell leukemia.

Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, Pucciarini A, Bigerna B, Pacini R, Wells VA, Sportoletti P, Pettirossi V, Mannucci R, Elliott O, Liso A, Ambrosetti A, Pulsoni A, Forconi F, Trentin L, Semenzato G, Inghirami G, Capponi M, Di Raimondo F, Patti C, Arcaini L, Musto P, Pileri S, Haferlach C, Schnittger S, Pizzolo G, Foà R, Farinelli L, Haferlach T, Pasqualucci L, Rabadan R, Falini B.

N Engl J Med. 2011 Jun 16;364(24):2305-15. doi: 10.1056/NEJMoa1014209. Epub 2011 Jun 11.

49.

A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia.

Tecchio C, Nichele I, Mosna F, Zampieri F, Leso A, Al-Khaffaf A, Veneri D, Andreini A, Pizzolo G, Ambrosetti A.

Eur J Haematol. 2011 Sep;87(3):228-34. doi: 10.1111/j.1600-0609.2011.01650.x. Epub 2011 Jul 26.

PMID:
21595749
50.

ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients.

Zanotti R, Frattini F, Ghia P, Visco C, Zamò A, Perbellini O, Stella S, Facco M, Giaretta I, Chilosi M, Pizzolo G, Ambrosetti A.

Am J Hematol. 2010 Jul;85(7):494-8. doi: 10.1002/ajh.21737.

Supplemental Content

Loading ...
Support Center